In summary, these findings showed that elevated expression of KIAA1429 reduced the sensitivity of CML cells to imatinib and inhibited the differentiation of CML cells, which could be a potential mechanism underlying the acute transformation of CML. This evidence concerns the gene VIRMA and chronic myelogenous leukemia, BCR-ABL1 positive.